Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neonatal alloimmune thrombopenia].

J Y Muller, C Patereau, M F Reznikoff-Etievant

    Revue Francaise De Transfusion Et Immuno-Hematologie
    |December 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    PO and ID BCG vaccination in humans induce distinct mucosal and systemic immune responses and CD4<sup>+</sup> T cell transcriptomal molecular signatures.

    Mucosal immunology·2017
    Same author

    Ashbya gossypii as a model system to study septin organization by single-molecule localization microscopy.

    Methods in cell biology·2016
    Same author

    Cellular Components Mediating Coadherence of Candida albicans and Fusobacterium nucleatum.

    Journal of dental research·2015
    Same author

    Anatomy of the fetal membranes using optical coherence tomography: part 1.

    Placenta·2014
    Same author

    Malnutrition and disability: unexplored opportunities for collaboration.

    Paediatrics and international child health·2014
    Same author

    Cation shifts in human retina-choroid.

    Biological trace element research·2013

    Neonatal alloimmune thrombocytopenia (NAT) often results from PLA system incompatibility, with HLA-DR3 increasing risk. Neurological sequelae affect 25% of survivors, but prevention via C-section and transfusions may help.

    Area of Science:

    • Obstetrics and Gynecology
    • Pediatrics
    • Immunology

    Context:

    • Neonatal alloimmune thrombocytopenia (NAT) is a significant cause of thrombocytopenia in newborns.
    • This study investigated 88 families with 84 cases of NAT, primarily linked to PLA system incompatibility.

    Purpose:

    • To analyze the causes, risk factors, clinical outcomes, and therapeutic strategies for neonatal alloimmune thrombocytopenia (NAT).
    • To evaluate the efficacy of interventions such as caesarean sections, platelet transfusions, and prenatal diagnosis.

    Summary:

    • 84% of NAT cases were due to PLA system incompatibility, with HLA-DR3 posing a 76.5-fold increased risk of immunization.
    • Neurological sequelae occurred in approximately 25% of surviving neonates.
    • NAT recurrence was frequent (59%) in subsequent pregnancies with PLA1-positive infants.

    Related Experiment Videos

  • Caesarean sections and compatible platelet transfusions showed utility, while prenatal transfusions and diagnosis at 20 weeks are promising.

    • Impact:

    • Highlights the significant risk of neurological sequelae in NAT survivors.
    • Provides evidence for the effectiveness of interventions like caesarean sections and platelet transfusions.
    • Suggests the feasibility and potential benefit of prenatal diagnosis and treatment for NAT.